Description
VPRIV MEDICATION REQUIRED TO TREAT PATIENTS WITH GAUCHER'S DISEASE
Base award description: IGF::OT::IGF VPRIV MEDICATION REQUIRED TO TREAT PATIENTS WITH GAUCHER'S DISEASE
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-01+$284,829= $284,829
- Mod P000012018-06-20-$5,720= $279,109
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-01 | +$284,829 | $284,829 | IGF::OT::IGF VPRIV MEDICATION REQUIRED TO TREAT PATIENTS WITH GAUCHER'S DISEASE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-06-20 | −$5,720 | $279,109 | VPRIV MEDICATION REQUIRED TO TREAT PATIENTS WITH GAUCHER'S DISEASE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Y12HDHECA8F6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0910 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $39,143 | FY2026 |
| 36C24226P0796 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $38,875 | FY2026 |
| 36C24526P0495 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $38,098 | FY2026 |
| 36C24526P0464 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $38,098 | FY2026 |
| 36C24226P0716 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $38,875 | FY2026 |
| 36C24226P0660 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $38,875 | FY2026 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0873 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $140,823 | FY2026 |
| 36C26226N0871 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $231,746 | FY2026 |
| 36C26226N0870 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $167,369 | FY2026 |
| 36C26226N0872 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $164,265 | FY2026 |
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26215P8360_3600_-NONE-_-NONE- · retrieved 2026-09-26.